CCR5在三阴性乳腺癌组织中的表达及其 对5年生存的影响(4)
[15] ZHANG Y， LV D， KIM H J， et al. A novel role of hematopoietic CCL5 in promoting triple-negative mammary tumor progression by regulating generation of myeloid-derived suppressor cells[J]. Cell Res， 2013， 23(3)： 394-408.
[16] PITTENGER M F， MACKAY A M， BECK S C， et al. Multilineage potential of adult human mesenchymal stem cells[J]. Science， 1999，284(5411)：143-147.
[17] KARNOUB A E， DASH A B， VO A P， et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis[J]. Nature， 2007， 449(7162)： 557-563.
[18] CHATURVEDI P， GILKES D M， TAKANO N， et al. Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment[J]. Proc Natl Acad Sci USA， 2014，111(20)：2120-2129.
[19] SWAMYDAS M， RICCI K， REGO S L， et al. Mesenchymal stem cell-derived CCL-9 and CCL-5 promote mammary tumor cell invasion and the activation of matrix metalloproteinases[J]. Cell Adh Migr， 2013，7(3)： 315-324.
[20] YANG Y， WOLFRAM J， SHEN J， et al. Live-cell single-molecule imaging reveals clathrin and caveolin-1 dependent docking of SMAD4 at the cell membrane[J]. FEBS Lett， 2013，587(24)：3912-3920.
[21] VELASCO-VELAZQUEZ M， PESTELL R G. The CCL5/CCR5 axis promotes metastasis in basal breast cancer[J]. Oncoimmunology， 2013，2(4)：e23660.
[22] LIN S， WAN S， SUN L， et al. Chemokine C-C motif receptor 5 and C-C motif ligand 5 promote cancer cell migration under hypoxia[J]. Cancer Sci， 2012，103(5)： 904-912.
[23] HARTMANN M C， DWYER R M， COSTELLO M， et al. Relationship between CCL5 and transforming growth factor-beta1 (TGFbeta1) in breast cancer[J]. Eur J Cancer， 2011，47(11)： 1669-1675.
[24] CHANG L Y， LIN Y C， MAHALINGAM J， et al. Tumor-derived chemokine CCL5 enhances TGF-beta-mediated killing of CD8(+) T cells in colon cancer by T-regulatory cells[J]. Cancer Res， 2012，72(5)： 1092-1102.
[25] TAMAMIS P， FLOUDAS C A. FLOUDAS C A. Elucidating a key anti-HIV-1 and cancer-associated axis： the structure of CCL5 (Rantes) in complex with CCR5[J]. Sci Rep， 2014，4：5447.
[26] VELASCO-VELAZQUEZ M， JIAO X， FUENTE M， et al. CCR5 antagonist blocks metastasis of basal breast cancer cells[J]. Cancer Res， 2012，72(15)： 3839-3850.
[27] 黃秉一，徐朝军，宋 岚.原花青素促进三阴性乳腺癌MDA-MB-231细胞凋亡的作用机制研究[J].湖南中医药大学学报，2017，37(11)：1196-1199., 百拇医药(胡慧钰 刘姝妍)
[16] PITTENGER M F， MACKAY A M， BECK S C， et al. Multilineage potential of adult human mesenchymal stem cells[J]. Science， 1999，284(5411)：143-147.
[17] KARNOUB A E， DASH A B， VO A P， et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis[J]. Nature， 2007， 449(7162)： 557-563.
[18] CHATURVEDI P， GILKES D M， TAKANO N， et al. Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment[J]. Proc Natl Acad Sci USA， 2014，111(20)：2120-2129.
[19] SWAMYDAS M， RICCI K， REGO S L， et al. Mesenchymal stem cell-derived CCL-9 and CCL-5 promote mammary tumor cell invasion and the activation of matrix metalloproteinases[J]. Cell Adh Migr， 2013，7(3)： 315-324.
[20] YANG Y， WOLFRAM J， SHEN J， et al. Live-cell single-molecule imaging reveals clathrin and caveolin-1 dependent docking of SMAD4 at the cell membrane[J]. FEBS Lett， 2013，587(24)：3912-3920.
[21] VELASCO-VELAZQUEZ M， PESTELL R G. The CCL5/CCR5 axis promotes metastasis in basal breast cancer[J]. Oncoimmunology， 2013，2(4)：e23660.
[22] LIN S， WAN S， SUN L， et al. Chemokine C-C motif receptor 5 and C-C motif ligand 5 promote cancer cell migration under hypoxia[J]. Cancer Sci， 2012，103(5)： 904-912.
[23] HARTMANN M C， DWYER R M， COSTELLO M， et al. Relationship between CCL5 and transforming growth factor-beta1 (TGFbeta1) in breast cancer[J]. Eur J Cancer， 2011，47(11)： 1669-1675.
[24] CHANG L Y， LIN Y C， MAHALINGAM J， et al. Tumor-derived chemokine CCL5 enhances TGF-beta-mediated killing of CD8(+) T cells in colon cancer by T-regulatory cells[J]. Cancer Res， 2012，72(5)： 1092-1102.
[25] TAMAMIS P， FLOUDAS C A. FLOUDAS C A. Elucidating a key anti-HIV-1 and cancer-associated axis： the structure of CCL5 (Rantes) in complex with CCR5[J]. Sci Rep， 2014，4：5447.
[26] VELASCO-VELAZQUEZ M， JIAO X， FUENTE M， et al. CCR5 antagonist blocks metastasis of basal breast cancer cells[J]. Cancer Res， 2012，72(15)： 3839-3850.
[27] 黃秉一，徐朝军，宋 岚.原花青素促进三阴性乳腺癌MDA-MB-231细胞凋亡的作用机制研究[J].湖南中医药大学学报，2017，37(11)：1196-1199., 百拇医药(胡慧钰 刘姝妍)